Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome

INTRODUCTION: Virtually all individuals with Down syndrome (DS) will develop Alzheimer's disease (AD) pathology by age 40. Cerebrospinal fluid (CSF) biomarkers have characterized AD pathology in cohorts of late‐onset AD (LOAD) and autosomal‐dominant AD (ADAD). Few studies have evaluated such bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Henson, Rachel L., Doran, Eric, Christian, Bradley T., Handen, Benjamin L., Klunk, William E., Lai, Florence, Lee, Joseph H., Rosas, H. Diana, Schupf, Nicole, Zaman, Shahid H., Lott, Ira T., Fagan, Anne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Diagnostic Assessment & Prognosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346867/
https://www.ncbi.nlm.nih.gov/pubmed/32671183
http://dx.doi.org/10.1002/dad2.12057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346867/
https://www.ncbi.nlm.nih.gov/pubmed/32671183
http://dx.doi.org/10.1002/dad2.12057

Ejemplares similares